| Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA) (NCT01532648) | Bausch Health Americas, Inc. | 2012-01-27 |
| Scintigraphic Evaluation of IPAA Function in Patients With Ulcerative Colitis (NCT02110862) | Odense University Hospital | 2012-01-01 |
| Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy (NCT01520324) | Cosmo Technologies Ltd | 2012-01-01 |
| Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis (NCT01494857) | Clalit Health Services | 2012-01-01 |
| Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD) (NCT01496053) | Oslo University Hospital | 2011-12-01 |
| TP0501 - Pharmaco-Scintigraphic-Study (NCT02306772) | Tillotts Pharma AG | 2011-12-01 |
| Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis (NCT01434576) | Human Genome Sciences Inc. | 2011-12-01 |
| Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate (NCT01991314) | Queen Mary University of London | 2011-12-01 |
| Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis (NCT01461317) | Genentech, Inc. | 2011-11-29 |
| Vitamin D and Disease Activity in Ulcerative Colitis (NCT02717897) | University of Chicago | 2011-11-01 |
| Disease Course in an IBD Cohort in the Era of Biological Treatment (NCT01468090) | Hvidovre University Hospital | 2011-10-01 |
| Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis (NCT01517594) | Ferring Pharmaceuticals | 2011-10-01 |
| Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Colonic Resection (NCT01339273) | Oxford University Hospitals NHS Trust | 2011-09-01 |
| Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis (NCT01336465) | Genentech, Inc. | 2011-09-01 |
| Endomicroscopy for Assessment of Mucosal Healing (NCT01417715) | University of Erlangen-Nürnberg Medical School | 2011-08-01 |
| Mind-Body Medicine and Ulcerative Colitis (NCT01491997) | Rush University Medical Center | 2011-08-01 |
| Endoscopy for Assessment of Mucosal Healing in IBD (NCT01417702) | University of Erlangen-Nürnberg Medical School | 2011-08-01 |
| Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis (NCT01320436) | Sheba Medical Center | 2011-07-01 |
| A Study Evaluating the Impact of an Educational Program (EDU-MICI) on Patients With Inflammatory Bowel Disease (NCT02550158) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2011-06-01 |
| Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative Colitis (NCT01387698) | Ferring Pharmaceuticals | 2011-06-01 |
| Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD) (NCT01346826) | Asan Medical Center | 2011-05-01 |
| Transplantation of Faeces in Ulcerative Colitis; Restoring Nature's Homeostasis (NCT01650038) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2011-05-01 |
| Endomicroscopy in IBD Patients (NCT01417728) | University of Erlangen-Nürnberg Medical School | 2011-05-01 |
| Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle (NCT01772615) | Hvidovre University Hospital | 2011-05-01 |
| Oral OKT3 for the Treatment of Active Ulcerative Colitis (NCT01287195) | Brigham and Women's Hospital | 2011-04-07 |
| Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients (NCT01341808) | Asan Medical Center | 2011-04-01 |
| Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease (NCT01349504) | Beth Israel Deaconess Medical Center | 2011-04-01 |
| Lactobacillus GG in Pediatric Ulcerative Colitis (UC) (NCT00895336) | Children's Hospital Medical Center, Cincinnati | 2011-03-01 |
| Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest. (NCT01517516) | University of California, Los Angeles | 2011-03-01 |
| Role of Healthy Bacteria in Ulcerative Colitis (NCT01479660) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2011-03-01 |
| Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis (NCT01408810) | Grupo de Estudo da Doença Inflamatória Intestinal | 2011-02-01 |
| Chromoendoscopy for Dysplasia Detection in Chronic Inflammatory Bowel Disease (NCT01505842) | Karolinska University Hospital | 2011-02-01 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181. (NCT01290042) | Amgen | 2011-02-01 |
| IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD. (NCT02130349) | Maastricht University Medical Center | 2011-02-01 |
| Epidemiology of IBD in Hong Kong: An Inception Cohort and Follow up Study (NCT02131168) | Chinese University of Hong Kong | 2011-01-01 |
| Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients (NCT01375179) | Novartis Pharmaceuticals | 2010-12-01 |
| Study of Cimzia for the Treatment of Ulcerative Colitis (NCT01090154) | University of Washington | 2010-12-01 |
| Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis (NCT01130844) | Shire | 2010-10-08 |
| Prognostic Indicators as Provided by the EPIC ClearView (NCT01476995) | Epic Research & Diagnostics, Inc. | 2010-09-01 |
| Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis (NCT01221428) | Qingdao University | 2010-09-01 |
| A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis (NCT01320332) | Telsar Pharma Inc. | 2010-08-01 |
| Trial on Profermin and Fresubin in Ulcerative Colitis (NCT01193894) | Nordisk Rebalance A/S | 2010-08-01 |
| Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease (NCT02319798) | Manchester University NHS Foundation Trust | 2010-07-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis (NCT01164904) | Amgen | 2010-07-01 |
| Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis (NCT01216280) | Natrogen Therapeutics International, Inc | 2010-07-01 |
| Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis (NCT01124149) | Shire | 2010-06-29 |
| Low-dose CT Using Iterative Reconstruction in Patients With Inflammatory Bowel Disease (NCT01244386) | University College Cork | 2010-06-01 |
| Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use (NCT00968721) | Vanderbilt University | 2010-06-01 |
| Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD) (NCT01289366) | University of Erlangen-Nürnberg Medical School | 2010-05-01 |
| Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis (NCT00572585) | Novartis Pharmaceuticals | 2010-04-01 |
| GWA Study in Patients With Inflammatory Bowel Disease (NCT01140789) | Chinese University of Hong Kong | 2010-04-01 |
| Clinical Outcome After Close Rectal Ileo Pouch Anal Anastomosis for Colitis Ulcerosa(CU) (NCT01111708) | University Medical Center Nijmegen | 2010-04-01 |
| A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis (NCT01097590) | IBD Column Therapies International AB | 2010-03-01 |
| Partial Wave Spectroscopic Detection of Colon Cancer Risk (NCT01095432) | University of Chicago | 2010-03-01 |
| Cannabidiol for Inflammatory Bowel Disease (NCT01037322) | Meir Medical Center | 2010-01-01 |
| Cannabis for Inflammatory Bowel Disease (NCT01040910) | Meir Medical Center | 2010-01-01 |
| Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity (NCT01065571) | University of Illinois at Chicago | 2010-01-01 |
| Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis (NCT01798953) | Sahlgrenska University Hospital | 2010-01-01 |
| Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis (NCT01059344) | Tillotts Pharma AG | 2009-11-01 |
| Metagenomic Analysis of Gut Microbiome in Korean Patients With Ulcerative Colitis (NCT01010815) | Seoul National University Hospital | 2009-11-01 |
| The Influence of Biologcal Treatment on the Short-Term Complications of Surgery in Patients With Inflematory Bowel Disease. (NCT03747068) | HaEmek Medical Center, Israel | 2009-10-09 |
| Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis (NCT01004185) | Warner Chilcott | 2009-10-01 |
| Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care (NCT01296841) | VA Palo Alto Health Care System | 2009-10-01 |
| An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal Surgery (NCT01002287) | Integra LifeSciences Corporation | 2009-10-01 |
| Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice (NCT02322008) | Regionshospitalet Viborg, Skive | 2009-09-01 |
| Study of Effects of L-Arginine in Colitis and Colon Cancer (NCT01091558) | Vanderbilt University Medical Center | 2009-09-01 |
| Trial of Chinese Prescription on Ulcerative Colitis (NCT00963287) | Shanghai University of Traditional Chinese Medicine | 2009-08-01 |
| Exacerbating Factors in Inflammatory Bowel Disease (NCT01405105) | Dallas VA Medical Center | 2009-08-01 |
| Microparticles in Pediatric Inflammatory Disease (NCT00979485) | Indiana University | 2009-08-01 |
| PillCam Colon Capsule Endoscopy for Ulcerative Colitis (NCT01467609) | Shanghai Jiao Tong University School of Medicine | 2009-07-01 |
| A Study to Assess the Safety and Tolerability of PUR 0110 Rectal Enema in Normal Healthy Volunteers (NCT01149694) | PurGenesis Technologies Inc. | 2009-06-01 |
| An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen (NCT00917514) | Medicpen AB | 2009-06-01 |
| Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis (NCT00961948) | Mayo Clinic | 2009-06-01 |
| An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease (NCT00790933) | Takeda | 2009-05-22 |
| Curcumin in Pediatric Inflammatory Bowel Disease (NCT00889161) | Seattle Children's Hospital | 2009-05-01 |
| A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC) (NCT00947674) | Asahi Kasei Medical Co., Ltd. | 2009-05-01 |
| Assessment of Colonic Permeability by Confocal Laser Endomicroscopy (NCT00883077) | Shandong University | 2009-04-01 |
| A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis (NCT00853099) | AbbVie (prior sponsor, Abbott) | 2009-02-01 |
| Profermin® in Active Ulcerative Colitis (NCT01245465) | Nordisk Rebalance A/S | 2009-01-01 |
| Synbiotic Treatment of Ulcerative Colitis Patients (NCT00803829) | University of Dundee | 2009-01-01 |
| Melatonin and Ulcerative Colitis: A Pilot Clinical Trial (NCT00790478) | Emory University | 2009-01-01 |
| Colon Capsule Endoscopy Versus Standard Colonoscopy in Ulcerative Colitis (NCT00837304) | University Hospital Muenster | 2009-01-01 |
| Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis (NCT00783718) | Millennium Pharmaceuticals, Inc. | 2009-01-01 |
| Prognosis in UC After First Biological (NCT05530122) | Tampere University Hospital | 2009-01-01 |
| A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis. (NCT00787202) | Pfizer | 2008-12-01 |
| Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis (NCT00713310) | Warner Chilcott | 2008-12-01 |
| (CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis. (NCT00801723) | Bausch Health Americas, Inc. | 2008-12-01 |
| A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis (NCT00808977) | Palau Pharma S.L.U. | 2008-12-01 |
| Endomicroscopy in Ulcerative Colitis (NCT00659867) | PENTAX Europe GmbH | 2008-12-01 |
| Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis. (NCT00737789) | Ferring Pharmaceuticals | 2008-11-01 |
| The Efficacy and Tolerability of Coltect as Add-on in Patients With Active Ulcerative Colitis - an Open Label (NCT00793130) | Tel-Aviv Sourasky Medical Center | 2008-11-01 |
| Hydrogen Sulfide Detoxification and Butyrate Metabolism in Ulcerative Colitis (NCT01282905) | KU Leuven | 2008-10-01 |
| Comparison Between Chromoendoscopy and Conventional Colonoscopy to Improve the Detection of Neoplasia in Patients With Ulcerative Colitis (UC) (NCT00816491) | Centre Hospitalier Universitaire de Nice | 2008-10-01 |
| Cognition and Emotion in the SII and IBD (NCT01095042) | University Hospital, Grenoble | 2008-10-01 |
| The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis (NCT00805285) | University of Maryland, Baltimore | 2008-10-01 |
| The Effect of Infliximab on Sperm Quality (NCT00745329) | Tel-Aviv Sourasky Medical Center | 2008-10-01 |
| Vaccines and Dietary Oats in the Treatment of Ulcerative Colitis (NCT00751933) | Haukeland University Hospital | 2008-10-01 |
| FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR (NCT00810030) | Vifor Pharma | 2008-10-01 |
| Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group (NCT00805428) | Clinical Hospital Center, Split | 2008-09-01 |
| Dose Escalation and Remission (DEAR) (NCT00652145) | James Lewis | 2008-09-01 |